The FDA has cleared the initiation of a pivotal Phase 3 trial testing pridopidine in people with early, rapidly progressive ...
ENV-308 is a first-in-class, once-daily oral therapy designed for chronic weight management, emphasizing high-quality weight loss with muscle mass preservation and durable long-term maintenancePhase 1 ...
Most oral cancer patients in India seek out medical assistance at stage three or four largely due to ignorance and delayed ...
Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today ...
Acquisition provides Virbac with a globally leading specialty product to improve the quality of life for senior cats.CARROS, ...
San Diego–based Ventyx Biosciences has what pharma wants, according to William Blair: two NLRP3 inhibitors for inflammatory ...
Pregnancy, menopause and hormone therapy may all impact a woman’s lipoprotein(a) level, challenging the mantra of the once-in ...
An announcement from BioNxt Solutions ( ($TSE:BNXT) ) is now available. BioNxt Solutions is advancing its proprietary ‘Melt in Your Mouth’ ...
The Chosun Ilbo on MSN
Oral obesity drugs near FDA approval, domestic launch planned
New obesity treatments such as 'oral Mounjaro' and 'high-dose Wegovy' are scheduled to be released next year. The U.S. Food ...
In a significant development for Bradford and Shipley residents, Taylored Dental Care in Idle has announced the expansion of ...
A federal appeals court has blocked Michigan’s ban on conversion therapy for minors who are LGBTQ+, declaring it violates the First Amendment rights of therapists and counselors. In a 2-1 ...
Immunome (IMNM) surges after positive phase 3 results for varegacestat in desmoid tumors. Read the latest analysis on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback